P14 2.25 Pill - white oval, 12mm
Pill with imprint P14 2.25 is White, Oval and has been identified as Pramipexole Dihydrochloride Extended Release 2.25 mg. It is supplied by Novast Laboratories, Ltd.
Pramipexole is used in the treatment of Restless Legs Syndrome; Periodic Limb Movement Disorder; Parkinson's Disease and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Pramipexole 2.25 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for P14 2.25
Pramipexole Dihydrochloride Extended Release
- Imprint
- P14 2.25
- Strength
- 2.25 mg
- Color
- White
- Size
- 12.00 mm
- Shape
- Oval
- Availability
- Prescription only
- Drug Class
- Dopaminergic antiparkinsonism agents
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Novast Laboratories, Ltd.
- National Drug Code (NDC)
- 50742-0334
More about pramipexole
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (234)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Drug class: dopaminergic antiparkinsonism agents
- Breastfeeding
- En español
Patient resources
- Pramipexole drug information
- Pramipexole (Advanced Reading)
- Pramipexole Extended-Release Tablets
- Pramipexole Tablets
Other brands
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.